MBA Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
MBA Advisors's PFE Position: Q2 2026 in Review
MBA Advisors increased its Pfizer (PFE) stake by 2.8% in Q2 2026, buying an estimated $15.9K and bringing the position to 22,463 shares worth $541K. The position accounts for 0.18% of the portfolio, ranked #90.
MBA Advisors first reported a position in PFE in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.08M in Q4 2021. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- MBA Advisors held 22,463 shares of Pfizer worth $541K as of Q2 2026.
- MBA Advisors bought 608 Pfizer shares in Q2 2026, an estimated $15.9K.
- Pfizer made up 0.18% of MBA Advisors's portfolio in Q2 2026, its #90 holding.
- MBA Advisors first reported a position in Pfizer in Q1 2021 and has held it in 22 quarters since.
- MBA Advisors's Pfizer position peaked at $1.08M in Q4 2021.
- 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on MBA Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.